1SCHEEPERS A, JOOST H G, SCHURMANN A. The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function [ J ]. JPEN J Parenter Enteral Nutr, 2004, 28(5) : 364 -371.
2WAI P Y, KUO P C. The role of osteopontin in tumor metastasis[J]. J Surg Res, 2004, 121(2):228-241.
3WINCEWICZ A, SULKOWSKA M, KODA M, et al. Clinicopathological significance and linkage of the distribution of HIF - 1 alpha and GLUT - 1 in human primary colorectal cancer[ J]. Pathol Oncol Res, 2007, 13(1) : 15 -20.
4MARKOWSKA J, GRABOWSKI J P, TOMASZEWSKA K, et al. Significance of Hypoxia in Uterine Cervical Cancer. Muhicentre study[J]. Eur J Gynaecol Oncol, 2007, 28(5) : 386 -388.
5ZHOU S, WANG S, WU Q, et al. Expression of glucose transporter - 1 and - 3 in the head and neck carcinoma the correlation of the expression with the biological behaviors[ J]. J Otorhinolaryngol Head Neck Surg, 2008, 70(3): 189- 194.
6JONATHAN R A, WIJFFELS K I, PEETERS W, et al. The prognostic value of endogenous hypoxia - related markers for head and neck squamous cell carcinomas treated with ARCON [J]. Radiother Oncol, 2006, 79(3): 288-297.
7YASUDA M, OGANE N, HAYASHI H, et al. Glucose transporter - 1 expression in the thyoid gland: clinicopathological significance for papillary carcinoma[J]. Oncol Rep, 2005, 14(6) : 1499 -1504.
8OLIVER R J, WOODWARDE R T, SLOAN P, et al. Prognostic value of facilitative glucose transporter Glut - 1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies[ J]. Eur J Cancer, 2004, 40 (4) : 503 - 507.
9ROH J L. CHO K J, KWON G Y, et al. The prognostic value of hypoxia markers in T2 - staged oral tongue cancer [ J ]. Oral Oncol, 2009, 45 ( 1 ), 63 - 68.
10LI S J, GUO W, REN G X, et al. Expression of Glut - 1 in primary and recurrent head and neck squamous cell carcinomas, and compared with 2 - [ 18F] fluoro -2 - deoxy - D - glucose accumulation in positron emission tomography[ J]. Br J Oral Maxillofac Surg, 2008, 46(3) : 180 - 186.
